Citius Pharmaceuticals, Inc. (CTXR)

Trade CTXR now with
12/19/2019 8:04:50 AM Citius Announces Positive Outcome Of Analysis For Phase 3 Mino-Lok Pivotal Trial; DMC Recommends Continuation Of Trial
9/25/2019 7:06:01 AM Citius Announces Pricing Of $7.0 Mln Underwritten Offering Priced At-the-Market
9/4/2019 6:57:01 AM Citius Says FDA Responded To Proposal To Refine Endpoints In Current Phase 3 Pivotal Trial For Mino-Lok
4/4/2019 8:31:42 AM Citius Pharmaceuticals Successfully Raises $5.3 Mln
12/19/2018 9:47:56 AM Citius Pharma Updates On Mino-Lok And CITI-002
9/27/2018 8:09:49 AM Citius Pharma Announces The Publication Of European Patent For Mino-Lok
8/15/2018 8:04:51 AM Citius Completes Capital Raise Of $10 Mln
8/9/2018 6:04:16 AM Citius Prices $10.0 Mln Offering Priced At-the-Market
7/24/2018 8:07:43 AM Citius Announces The Notice Of Allowance From USPTO On The Advanced Stability Patent Application For Mino-Lok
7/9/2018 8:11:08 AM Citius Pharma Provides Clinical Update And Progress Of The Mino-Lok Phase 3 Trial
6/19/2018 8:19:03 AM Citius Announces Mino-Lok Is Now Registered Trademark With PTO
3/29/2018 8:10:27 AM Citius Reports $2.0 Mln Direct Offering